Christopher Faulkner is a Senior Scientist in the Research and Development team at Optibrium, where they contribute their expertise in computational chemistry. They previously held the position of Computational Chemist at BioAscent from 2022 to 2025, applying structure and ligand-based drug design methods to advance various projects. Christopher earned a PhD in Computational Chemistry from Cardiff University in 2022 and holds an MChem in Chemistry from the University of Strathclyde, which they completed in 2017.
This person is not in the org chart
This person is not in any teams
This person is not in any offices